Open AccessIs management with lamivudine always the appropriate choice for HBV patients with onco-hematologic diseases?
Author(s) -
Maria Christina Cox,
Massimo Marignani,
Barbara Veggia,
Stefano Angeletti,
Francesco Leone,
Paola Cipriani,
Sara Gallina,
Gianfranco Delle Fave,
Maria Antonietta Aloe Spiriti,
Bruno Monarca
Publication year - 2008
Publication title -
annals of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.079
H-Index - 80
eISSN - 1432-0584
pISSN - 0939-5555
DOI - 10.1007/s00277-008-0609-2
Subject(s) - medicine , lamivudine , hbsag , rituximab , hepatitis b , serology , hbeag , lymphoma , hepatitis b virus , gastroenterology , immunology , antibody , virus
International audienc
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom